Edition:
United Kingdom

Marksans Pharma Ltd (MARK.NS)

MARK.NS on National Stock Exchange of India

44.40INR
19 Jan 2018
Change (% chg)

Rs0.45 (+1.02%)
Prev Close
Rs43.95
Open
Rs44.25
Day's High
Rs44.90
Day's Low
Rs43.10
Volume
3,574,926
Avg. Vol
5,160,705
52-wk High
Rs58.25
52-wk Low
Rs34.20

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -- March 20 Jan 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 1 1 2 2
(3) HOLD 1 1 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.50 2.50 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Mar-18 2 10,224.00 10,296.00 10,152.00 10,214.00
Year Ending Mar-19 2 11,892.50 12,152.00 11,633.00 --
Earnings (per share)
Year Ending Mar-18 2 1.50 1.70 1.30 2.65
Year Ending Mar-19 2 2.70 2.90 2.50 --

Historical Surprises

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 2,245.50 2,738.09 492.59 21.94
Quarter Ending Jun-17 1,958.50 2,210.56 252.06 12.87
Quarter Ending Mar-17 2,237.50 1,847.49 390.01 17.43
Quarter Ending Dec-16 2,035.00 2,152.39 117.39 5.77
Quarter Ending Sep-16 2,100.00 1,804.26 295.74 14.08
Earnings (per share)
Quarter Ending Sep-15 0.81 0.85 0.04 4.94

Consensus Estimates Trend

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Mar-18 10,224.00 10,224.00 10,224.00 9,844.50 10,214.00
Year Ending Mar-19 11,892.50 11,892.50 11,892.50 11,724.50 --
Earnings (per share)
Year Ending Mar-18 1.50 1.50 1.50 1.60 2.65
Year Ending Mar-19 2.70 2.70 2.70 2.80 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Mar-18 0 0 0 0
Year Ending Mar-19 0 0 0 0
Earnings
Year Ending Mar-18 0 0 0 0
Year Ending Mar-19 0 0 0 0